Edwards Lifesciences Retained Earnings (Accumulated Deficit) 2010-2025 | EW
Edwards Lifesciences retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Edwards Lifesciences retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $13.525B, a 44.74% increase year-over-year.
- Edwards Lifesciences retained earnings (accumulated deficit) for 2024 were $13.167B, a 46.42% increase from 2023.
- Edwards Lifesciences retained earnings (accumulated deficit) for 2023 were $8.992B, a 18.48% increase from 2022.
- Edwards Lifesciences retained earnings (accumulated deficit) for 2022 were $7.59B, a 25.08% increase from 2021.
| Edwards Lifesciences Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $13,167 |
| 2023 | $8,992 |
| 2022 | $7,590 |
| 2021 | $6,068 |
| 2020 | $4,565 |
| 2019 | $3,742 |
| 2018 | $2,695 |
| 2017 | $1,962 |
| 2016 | $3,906 |
| 2015 | $3,337 |
| 2014 | $2,842 |
| 2013 | $2,031 |
| 2012 | $1,654 |
| 2011 | $1,361 |
| 2010 | $1,124 |
| 2009 | $906 |
| Edwards Lifesciences Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $13,525 |
| 2024-12-31 | $13,167 |
| 2024-09-30 | $12,781 |
| 2024-06-30 | $9,711 |
| 2024-03-31 | $9,344 |
| 2023-12-31 | $8,992 |
| 2023-09-30 | $8,623 |
| 2023-06-30 | $8,238 |
| 2023-03-31 | $7,931 |
| 2022-12-31 | $7,590 |
| 2022-09-30 | $7,192 |
| 2022-06-30 | $6,848 |
| 2022-03-31 | $6,442 |
| 2021-12-31 | $6,068 |
| 2021-09-30 | $5,733 |
| 2021-06-30 | $5,393 |
| 2021-03-31 | $4,903 |
| 2020-12-31 | $4,565 |
| 2020-09-30 | $4,256 |
| 2020-06-30 | $3,930 |
| 2020-03-31 | $4,052 |
| 2019-12-31 | $3,742 |
| 2019-09-30 | $3,461 |
| 2019-06-30 | $3,187 |
| 2019-03-31 | $2,944 |
| 2018-12-31 | $2,695 |
| 2018-09-30 | $2,688 |
| 2018-06-30 | $2,462 |
| 2018-03-31 | $2,179 |
| 2017-12-31 | $1,962 |
| 2017-09-30 | $1,965 |
| 2017-06-30 | $4,332 |
| 2017-03-31 | $4,146 |
| 2016-12-31 | $3,906 |
| 2016-09-30 | $3,748 |
| 2016-06-30 | $3,606 |
| 2016-03-31 | $3,480 |
| 2015-12-31 | $3,337 |
| 2015-09-30 | $3,196 |
| 2015-06-30 | $3,078 |
| 2015-03-31 | $2,965 |
| 2014-12-31 | $2,842 |
| 2014-09-30 | $2,733 |
| 2014-06-30 | $2,638 |
| 2014-03-31 | $2,091 |
| 2013-12-31 | $2,031 |
| 2013-09-30 | $1,970 |
| 2013-06-30 | $1,893 |
| 2013-03-31 | $1,799 |
| 2012-12-31 | $1,654 |
| 2012-09-30 | $1,563 |
| 2012-06-30 | $1,494 |
| 2012-03-31 | $1,426 |
| 2011-12-31 | $1,361 |
| 2011-09-30 | $1,298 |
| 2011-06-30 | $1,246 |
| 2011-03-31 | $1,188 |
| 2010-12-31 | $1,124 |
| 2010-09-30 | $1,059 |
| 2010-06-30 | $1,011 |
| 2010-03-31 | $954 |
| 2009-12-31 | $906 |
| 2009-09-30 | $858 |
| 2009-06-30 | $785 |
| 2009-03-31 | $737 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.596B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.191B | 87.25 |
| Thermo Fisher Scientific (TMO) | United States | $152.413B | 18.44 |
| Alcon (ALC) | Switzerland | $42.592B | 28.78 |
| IDEXX Laboratories (IDXX) | United States | $41.462B | 47.65 |
| DexCom (DXCM) | United States | $33.274B | 51.43 |
| IQVIA Holdings (IQV) | United States | $24.396B | 13.66 |
| Mettler-Toledo (MTD) | United States | $24.382B | 29.00 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Waters (WAT) | United States | $21.144B | 29.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.666B | 0.00 |
| Hologic (HOLX) | United States | $14.021B | 15.23 |
| Sysmex ADR (SSMXY) | Japan | $10.468B | 29.70 |
| Penumbra (PEN) | United States | $10.283B | 80.71 |
| Masimo (MASI) | United States | $8.511B | 31.39 |
| Globus Medical (GMED) | United States | $7.972B | 19.00 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| Teleflex (TFX) | United States | $5.414B | 8.94 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| PROCEPT BioRobotics (PRCT) | United States | $3.082B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.111B | 29.63 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.054B | 23.56 |
| Alphatec Holdings (ATEC) | United States | $1.821B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.200B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.24 |
| SiBone (SIBN) | United States | $0.809B | 0.00 |
| IRadimed (IRMD) | United States | $0.739B | 37.51 |
| Beta Bionics (BBNX) | United States | $0.666B | 0.00 |
| RxSight (RXST) | United States | $0.660B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.571B | 13.38 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.494B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.447B | 11.89 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| NeuroPace (NPCE) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.70 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |